In the realm of pharmaceutical manufacturing, understanding the detailed properties of key chemical intermediates is crucial for successful synthesis and product development. (alphaR)-alpha-Hydroxy-N-[2-(4-nitrophenyl)ethyl]benzeneacetamide, bearing the CAS number 521284-19-5, is a prime example of such an indispensable compound. Its specific attributes make it a valuable asset in the creation of vital medicines, particularly those targeting diabetes.

As a leading pharmaceutical intermediate supplier and manufacturer in China, we focus on delivering compounds with well-defined characteristics. (alphaR)-alpha-Hydroxy-N-[2-(4-nitrophenyl)ethyl]benzeneacetamide presents as an Off-White to Pale Yellow Solid, with a molecular formula of C16H16N2O4 and a molecular weight of 300.31. These fundamental details are critical for its application in complex organic synthesis and pharmaceutical intermediate production.

The compound's melting point, typically ranging from 116-119°C, along with its density of 1.294 g/cm³, provides essential physical data for handling and processing. Its solubility characteristics, being slightly soluble in DMSO and Methanol, guide chemists in selecting appropriate reaction solvents. When companies seek to buy such intermediates, these precise properties dictate the feasibility and efficiency of their synthetic routes.

The primary application of (alphaR)-alpha-Hydroxy-N-[2-(4-nitrophenyl)ethyl]benzeneacetamide is its role as a pharmaceutical intermediate. It is instrumental in the synthesis of (aminothiazolyl)acetanilide derivatives, which are actively researched for their therapeutic benefits in treating diabetes. This connection underscores its importance in the pharmaceutical supply chain, linking it to ongoing advancements in medical science.

Furthermore, its identity as a Mirabegron intermediate reinforces its significance. Mirabegron is a therapeutic agent that requires specific, high-quality intermediates for its manufacturing process. Our role as a manufacturer in China is to ensure a stable and reliable supply of such compounds, facilitating both research and commercial production. The price for bulk quantities is a key consideration for global accessibility.

In conclusion, (alphaR)-alpha-Hydroxy-N-[2-(4-nitrophenyl)ethyl]benzeneacetamide is a compound of significant value in the pharmaceutical industry. Its well-documented chemical and physical properties, combined with its critical applications in areas like diabetes treatment, make it a key intermediate for drug discovery and development. Partnering with experienced manufacturers in China ensures access to this essential building block for future pharmaceutical innovations.